Forty Seven, Inc. (FTSV) News
Filter FTSV News Items
FTSV News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest FTSV News From Around the Web
Below are the latest news stories about Forty Seven Inc that investors may wish to consider to help them evaluate FTSV as an investment opportunity.
The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend InitiationHere's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 6.) Forty Seven Inc (NASDAQ: FTSV ) Masimo Corporation (NASDAQ: MASI ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) Down In The Dumps (Biotech stocks that hit 52-week lows April 6) BIOLASE Inc (NASDAQ: BIOL ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) ENDRA Life Sciences Inc (NASDAQ: NDRA ) Global Cord Blood Corp (NYSE: CO ) ImmuCell Corporation (NASDAQ: ICCC ) IMMURON LTD/S ADR (NASDAQ: IMRN ) Menlo Therapeutics Inc (NASDAQ: MNLO ) (flunked two late-stage studies that evaluated oral serlopitant for treating pruritus associated with prurigo nodularis) Merus NV (NASDAQ: MRUS ) Millendo Therapeutic... |
The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus TestsHere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 31) Athersys Inc (NASDAQ: ATHX ) Forty Seven Inc (NASDAQ: FTSV ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Quidel Corporation (NASDAQ: QDEL ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 31) Aikido Pharma Inc (NASDAQ: AIKI ) BIOLASE Inc (NASDAQ: BIOL ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Gritstone Oncology Inc (NASDAQ: GRTS ) Neovasc Inc (NASDAQ: NVCN )(moved in reaction to its fourth quarter results) Opko Health Inc. (NASDAQ: OPK ) Phio Pharmaceuticals Corp (NASDAQ: PHIO )(announced $4 million registered offering) Second Sight Medical Products Inc (NASDAQ: EYES ) Related Link: Amarin Analysts React To Vascepa Patent Loss, See... |
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 TreatmentHere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu Bioscience Inc (NASDAQ: AYTU ) ( announced a deal to distribute COVID-19 test) Centogene NV (NASDAQ: CNTG ) Forty Seven Inc (NASDAQ: FTSV ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 10) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Aldeyra Therapeutics Inc (NASDAQ: A... |
The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage StudyHere's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) Arcus Biosciences Inc (NYSE: RCUS ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Centogene NV (NASDAQ: CNTG ) Cue Biopharma Inc (NASDAQ: CUE ) Forty Seven Inc (NASDAQ: FTSV ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Molecular Templates Inc (NASDAQ: MTEM ) Natera Inc (NASDAQ: NTRA ) Ocular Therapeutix Inc (NASDAQ: OCUL ) (Piper Sandler lifted the price target for the shares from $7 to $11) Quest Diagnostics Inc (NYSE: DGX ) (announced plans to launch a COVID-19 test service) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Zynex Inc. (NASDAQ: ZYXI ) Down I... |
The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics CompaniesHere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 3) Acceleron Pharma Inc (NASDAQ: XLRN ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Fate Therapeutics Inc (NASDAQ: FATE ) (reacted to its fourth-quarter results) Forty Seven Inc (NASDAQ: FTSV ) IGM Biosciences Inc (NASDAQ: IGMS ) Inovio Pharmaceuticals Inc (NASDAQ: INO )( announced an accelerated timeline for COVID-19 vaccine development) Repro-Med Systems, Inc. (NASDAQ: KRMD ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 3) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) ANI Pharmaceuticals Inc ... |
The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And MoreHere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 2) Forty Seven Inc (NASDAQ: FTSV )( announced a deal to be bought by Gilead Sciences, Inc. (NASDAQ: GILD )) IGM Biosciences Inc (NASDAQ: IGMS ) Iovance Biotherapeutics Inc (NASDAQ: IOVA ) Karyopharm Therapeutics Inc (NASDAQ: KPTI )(announced positive late-stage results for selinexor) Passage Bio Inc (NASDAQ: PASG )(IPOed Friday) Syneos Health Inc (NASDAQ: SYNH ) Trillium Therapeutics Inc (NASDAQ: TRIL )(moved in sympathy with Forty Seven, as it has a similar drug in the pipeline for solid tumor) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 2) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zenta... |
Gilead Confirms Deal To Buy Biotech Forty Seven For $4.9BForty Seven Inc (NASDAQ: FTSV ) shares were skyrocketing Monday morning, adding on to the roughly 19% gain the stock made Friday, after Gilead Sciences, Inc. (NASDAQ: GILD ) agreed to buy the smaller biotech. The move was expected: a Bloomberg report late Thursday said Gilead approached Forty Seven regarding a potential takeover, but also suggested other parties were interested as well. Gilead, Forty Seven's Deal Terms Gilead said in a Monday press release that it has entered into a definitive agreement to acquire Menlo Park, California-based Forty Seven for $95.50 per share in cash, or $4.9 billion. This per-share value represents a 96% premium to the … Full story available on Benzinga.com |
Forty Seven's stock rockets Gilead's $4.9 billion buyout dealShares of Forty Seven Inc. shot up 61% in premarket trading Monday, after the immuno-oncology company agreed to be acquired by Gilead Sciences Inc. in a cash… |
Gilead to Acquire Forty Seven for $4.9 BillionGilead Sciences, Inc. (Nasdaq: GILD) and Forty Seven, Inc. (Nasdaq: FTSV) announced today that the companies have entered into a definitive agreement |
Forty Seven M&A News: FTSV Stock Soars 62% on $4.9B Gilead DealForty Seven (FTSV) M&A news is seeing FTSV stock soar higher on Monday following news of a $4.9 billion deal with Gilead (GILD). |